How many institutions held ABUS - Arbutus Biopharma Corp - Common Shares, without par value in Q1 2016?

47 institutional investors reported ABUS - Arbutus Biopharma Corp - Common Shares, without par value for Q1 2016. Use the holders table for investor-level position and value details.

Arbutus Biopharma Corp - Common Shares, without par value (ABUS)

Q: What does CUSIP 03879J100 represent in this 13F holders report?

CUSIP 03879J100 is the security identifier for ABUS - Arbutus Biopharma Corp - Common Shares, without par value used to aggregate holder disclosures.

CUSIP: 03879J100

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class: Equity / Common Shares, without par value
Shares outstanding: 197,428,263
Total 13F shares: 17,711,768
Share change: -666,080
Total reported value: $73,144,106
Put/Call ratio: 137%
Price per share: $4.13
Number of holders: 47
Value change: -$3,356,008
Number of buys: 21
Number of sells: 24

Quarterly Holders Quick Answers

What is CUSIP 03879J100?
CUSIP 03879J100 identifies ABUS - Arbutus Biopharma Corp - Common Shares, without par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2016
Previous quarter: Q4 2015

Recent filing periods for CUSIP 03879J100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ABUS - Arbutus Biopharma Corp - Common Shares, without par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
PRIMECAP MANAGEMENT CO/CA/	13F	Company	1.5%	2,930,982	$13,043,000	—	31 Dec 2015	13F
Alpha Wave Global, LP	13F	Company	1.3%	2,618,000	$11,650,000	—	31 Dec 2015	13F
HealthCor Management, L.P.	13F	Company	1.1%	2,189,200	$9,742,000	—	31 Dec 2015	13F
D. E. Shaw & Co., Inc.	13F	Company	0.95%	1,871,460	$8,328,000	—	31 Dec 2015	13F
FRANKLIN RESOURCES INC	13F	Company	0.65%	1,287,560	$5,730,000	—	31 Dec 2015	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.61%	1,204,445	$5,360,000	—	31 Dec 2015	13F
SABBY MANAGEMENT, LLC	13F	Company	0.51%	1,000,000	$4,450,000	—	31 Dec 2015	13F
AXA S.A.	13F	Company	0.4%	781,296	$3,477,000	—	31 Dec 2015	13F
BANK OF MONTREAL /CAN/	13F	Company	0.39%	769,770	$3,425,000	—	31 Dec 2015	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.34%	675,056	$3,004,000	—	31 Dec 2015	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.23%	454,500	$2,023,000	—	31 Dec 2015	13F
SUFFOLK CAPITAL MANAGEMENT LLC	13F	Company	0.18%	361,897	$1,610,000	—	31 Dec 2015	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.18%	356,000	$1,584,000	—	31 Dec 2015	13F
CITADEL ADVISORS LLC	13F	Company	0.14%	269,245	$1,198,000	—	31 Dec 2015	13F
DEUTSCHE BANK AG\	13F	Company	0.09%	183,514	$816,000	—	31 Dec 2015	13F
BAKER BROS. ADVISORS LP	13F	Company	0.09%	180,582	$804,000	—	31 Dec 2015	13F
CREDIT SUISSE AG/	13F	Company	0.09%	176,231	$785,000	—	31 Dec 2015	13F
MARINER INVESTMENT GROUP LLC	13F	Company	0.08%	153,133	$681,000	—	31 Dec 2015	13F
Bellevue Asset Management AG	13F	Company	0.06%	125,000	$556,000	—	31 Dec 2015	13F
Telemetry Investments, L.L.C.	13F	Company	0.05%	101,000	$449,000	—	31 Dec 2015	13F
S.c.a. Candriam	13F	Individual	0.05%	100,000	$445,000	—	31 Dec 2015	13F
VANGUARD GROUP INC	13F	Company	0.04%	72,450	$322,000	—	31 Dec 2015	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.03%	68,033	$303,000	—	31 Dec 2015	13F
LANDSCAPE CAPITAL MANAGEMENT, L.L.C.	13F	Company	0.03%	55,273	$246,000	—	31 Dec 2015	13F
TFS CAPITAL LLC	13F	Company	0.02%	47,284	$210,000	—	31 Dec 2015	13F
MACKENZIE FINANCIAL CORP	13F	Company	0.02%	39,900	$178,000	—	31 Dec 2015	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.02%	32,869	$146,000	—	31 Dec 2015	13F
CAXTON CORP	13F	Company	0.02%	29,762	$132,000	—	31 Dec 2015	13F
Stanley-Laman Group, Ltd.	13F	Company	0.01%	25,722	$114,000	—	31 Dec 2015	13F
Trexquant Investment LP	13F	Company	0.01%	24,028	$107,000	—	31 Dec 2015	13F
MORGAN STANLEY	13F	Company	0.01%	22,018	$98,000	—	31 Dec 2015	13F
Airain ltd	13F	Company	0.01%	20,582	$92,000	—	31 Dec 2015	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.01%	20,346	$90,000	—	31 Dec 2015	13F
GROUP ONE TRADING LLC	13F	Company	0.01%	20,253	$90,000	—	31 Dec 2015	13F
FMR LLC	13F	Company	0.01%	19,200	$85,000	—	31 Dec 2015	13F
ROYAL BANK OF CANADA	13F	Company	0.01%	15,350	$68,000	—	31 Dec 2015	13F
ROCKEFELLER FINANCIAL SERVICES INC	13F	Company	0.01%	13,932	$62,000	—	31 Dec 2015	13F
CITIGROUP INC	13F	Company	0.01%	13,050	$58,000	—	31 Dec 2015	13F
STATE STREET CORP	13F	Company	0.01%	12,715	$57,000	—	31 Dec 2015	13F
UBS Group AG	13F	Company	0%	8,059	$35,000	—	31 Dec 2015	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	7,666	$35,000	—	31 Dec 2015	13F
Cutler Group LLC / CA	13F	Company	0%	4,580	$20,000	—	31 Dec 2015	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	2,870	$13,000	—	31 Dec 2015	13F
SIMPLEX TRADING, LLC	13F	Company	0%	2,635	$11,000	—	31 Dec 2015	13F
Creative Planning	13F	Company	0%	1,500	$7,000	—	31 Dec 2015	13F
WOODMONT INVESTMENT COUNSEL LLC	13F	Company	0%	800	$4,000	—	31 Dec 2015	13F
Wealthspire Advisors, L.P.	13F	Company	0%	600	$3,000	—	31 Dec 2015	13F
US BANCORP \DE\	13F	Company	0%	300	$1,000	—	31 Dec 2015	13F

Institutional Holders of Arbutus Biopharma Corp - Common Shares, without par value (ABUS) as of Q1 2016

As of 31 Mar 2016, Arbutus Biopharma Corp - Common Shares, without par value (ABUS) was held by 47 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 17,711,768 shares. The largest 10 holders included PRIMECAP MANAGEMENT CO/CA/, Falcon Edge Capital LP, HealthCor Management, L.P., D. E. Shaw & Co., Inc., SABBY MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, BANK OF MONTREAL /CAN/, AXA, GOLDMAN SACHS GROUP INC, and SPHERA FUNDS MANAGEMENT LTD.. This page lists 47 institutional shareholders reporting positions in this security for the Q1 2016 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2016 vs Q4 2015 Across Filers

Q4 2015 holders

Q1 2016 holders

Holder diff

Investor	Q4 2015 Shares	Q1 2016 Shares	Share Diff	Share Chg %	Q4 2015 Value $	Q1 2016 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.